These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16873891)

  • 1. Monolysocardiolipin in cultured fibroblasts is a sensitive and specific marker for Barth Syndrome.
    van Werkhoven MA; Thorburn DR; Gedeon AK; Pitt JJ
    J Lipid Res; 2006 Oct; 47(10):2346-51. PubMed ID: 16873891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis.
    Valianpour F; Mitsakos V; Schlemmer D; Towbin JA; Taylor JM; Ekert PG; Thorburn DR; Munnich A; Wanders RJ; Barth PG; Vaz FM
    J Lipid Res; 2005 Jun; 46(6):1182-95. PubMed ID: 15805542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.
    Houtkooper RH; Rodenburg RJ; Thiels C; van Lenthe H; Stet F; Poll-The BT; Stone JE; Steward CG; Wanders RJ; Smeitink J; Kulik W; Vaz FM
    Anal Biochem; 2009 Apr; 387(2):230-7. PubMed ID: 19454236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome.
    Kulik W; van Lenthe H; Stet FS; Houtkooper RH; Kemp H; Stone JE; Steward CG; Wanders RJ; Vaz FM
    Clin Chem; 2008 Feb; 54(2):371-8. PubMed ID: 18070816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype.
    Bowron A; Honeychurch J; Williams M; Tsai-Goodman B; Clayton N; Jones L; Shortland GJ; Qureshi SA; Heales SJ; Steward CG
    J Inherit Metab Dis; 2015 Mar; 38(2):279-86. PubMed ID: 25112388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
    Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid abnormalities in children with Barth syndrome.
    Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
    J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis.
    Bowron A; Frost R; Powers VE; Thomas PH; Heales SJ; Steward CG
    J Inherit Metab Dis; 2013 Sep; 36(5):741-6. PubMed ID: 23109063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients.
    Valianpour F; Wanders RJ; Barth PG; Overmars H; van Gennip AH
    Clin Chem; 2002 Sep; 48(9):1390-7. PubMed ID: 12194913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model.
    Bozelli JC; Lu D; Atilla-Gokcumen GE; Epand RM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158677. PubMed ID: 32126285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.
    Vaz FM; van Lenthe H; Vervaart MAT; Stet FS; Klinkspoor JH; Vernon HJ; Goorden SMI; Houtkooper RH; Kulik W; Wanders RJA
    J Inherit Metab Dis; 2022 Jan; 45(1):29-37. PubMed ID: 34382226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.
    Duncan AL
    Biochem Soc Trans; 2020 Jun; 48(3):993-1004. PubMed ID: 32453413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription.
    Ferri L; Dionisi-Vici C; Taurisano R; Vaz FM; Guerrini R; Morrone A
    Clin Genet; 2016 Nov; 90(5):461-465. PubMed ID: 26853223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
    Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalous peroxidase activity of cytochrome c is the primary pathogenic target in Barth syndrome.
    Kagan VE; Tyurina YY; Mikulska-Ruminska K; Damschroder D; Vieira Neto E; Lasorsa A; Kapralov AA; Tyurin VA; Amoscato AA; Samovich SN; Souryavong AB; Dar HH; Ramim A; Liang Z; Lazcano P; Ji J; Schmidtke MW; Kiselyov K; Korkmaz A; Vladimirov GK; Artyukhova MA; Rampratap P; Cole LK; Niyatie A; Baker EK; Peterson J; Hatch GM; Atkinson J; Vockley J; Kühn B; Wessells R; van der Wel PCA; Bahar I; Bayir H; Greenberg ML
    Nat Metab; 2023 Dec; 5(12):2184-2205. PubMed ID: 37996701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barth syndrome in a female patient.
    Cosson L; Toutain A; Simard G; Kulik W; Matyas G; Guichet A; Blasco H; Maakaroun-Vermesse Z; Vaillant MC; Le Caignec C; Chantepie A; Labarthe F
    Mol Genet Metab; 2012 May; 106(1):115-20. PubMed ID: 22410210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
    Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment.
    Valianpour F; Wanders RJ; Overmars H; Vaz FM; Barth PG; van Gennip AH
    J Lipid Res; 2003 Mar; 44(3):560-6. PubMed ID: 12562862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts.
    Valianpour F; Wanders RJ; Overmars H; Vreken P; Van Gennip AH; Baas F; Plecko B; Santer R; Becker K; Barth PG
    J Pediatr; 2002 Nov; 141(5):729-33. PubMed ID: 12410207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.